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Most genetic disruptions underlying human disease are microlesions, whereas gross lesions are rare with gross deletions being most
frequently found (6%). Similar observations have been made in primary immunodeﬁciency genes, such as BTK, but for unknown
reasons the IGHM and DCLRE1C (Artemis) gene defects frequently represent gross deletions (~60%). We characterized the gross deletion
breakpoints in IGHM-, BTK-, and Artemis-deﬁcient patients. The IGHM deletion breakpoints did not show involvement of recombina-
tion signal sequences or immunoglobulin switch regions. Instead, ﬁve IGHM, eight BTK, and ﬁve unique Artemis breakpoints were
located in or near sequences derived from transposable elements (TE). The breakpoints of four out of ﬁve disrupted Artemis alleles
were located in highly homologous regions, similar to Ig subclass deﬁciencies and VH deletion polymorphisms. Nevertheless, these
observations suggest a role for TEs in mediating gross deletions. The identiﬁed gross deletion breakpoints were mostly located in TE
subclasses that were speciﬁcally overrepresented in the involved gene as compared to the average in the human genome. This concerned
both long (LINE1) and short (Alu, MIR) interspersed elements, as well as LTR retrotransposons (ERV). Furthermore, a high total TE con-
tent (>40%) was associated with an increased frequency of gross deletions. Both ﬁndings were further investigated and conﬁrmed in
a total set of 20 genes disrupted in human disease. Thus, to our knowledge for the ﬁrst time, we provide evidence that a high TE content,
irrespective of the type of element, results in the increased incidence of gross deletions as gene disruption underlying human disease.Introduction
The majority of gene disruptions underlying human in-
herited diseases aremicrolesions, i.e., single basepair substi-
tutions (68%) and small (<20 nt) deletions or insertions
(25%).1 Gross lesions are less common, with gross deletions
being most frequently found (6%).1 For gross deletions to
occur, three conditions have to bemet: (1) double-stranded
DNA breaks in two distinct genomic locations that are (2)
physically located in close proximity and joined by (3)
incorrect repair. Based on limited sequence data of the junc-
tions of gross deletion breakpoints in disease-causing
alleles, two mechanisms have been described: (1) mispair-
ing of homologous sequences and unequal crossing over;
and (2) nonhomologous deletions.2 Recent analysis of sev-
eral gross deletion breakpoints indicates a role for single-
strand annealing of repeated fragments in gross lesions.3
Although this mechanism could explain incorrect repair
of complex DNA structures, it remains unclear how two ge-
nomically distinct sites become located in close proximity.
Thehumangenomecontains fourclassesof frequently re-
curring sequences, called interspersed repeats,whichare de-
rived from transposable elements (TE) and comprise about320 The American Journal of Human Genetics 82, 320–332, Februar45% of the total genome sequence.4 The four classes are
short interspersed elements (SINE), long interspersed ele-
ments (LINE), LTR retrotransposons, andDNA transposons.
Nonhomologous gross deletion breakpoints are frequently
located inornear these TEs,5,6 but the role of these elements
in mediating gross deletions is currently unknown.
Although inherited disorders of the immune system are
rare, multiple gene defects have been identiﬁed during the
last 15 years, mainly concerning microlesions.7 However,
gross deletions have also been found, for example involv-
ing the DCLRE1C (Artemis [MIM 605988]), BTK (MIM
300300), and immunoglobulin Cm heavy chain (IGHM
[MIM 147020]) genes.8–13 The gross deletion frequency of
BTK disruptions is 6%, whereas more than half of the re-
ported disease-causing alleles of IGHM and Artemis are dis-
rupted by gross deletions.1,8,13 A mechanism underlying
this striking difference has never been reported.
The immunoglobulin heavy chain (IgH) is part of the
antibody molecule and is produced by B cells after V(D)J
recombination of the IGH locus. The IGH locus contains
multiple VH, DH, and JH gene segments and constant (CH)
regions. The VH, DH, and JH gene segments are ﬂanked by
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by the recombinase machinery,14 which mediates rear-
rangement of the VH, DH, and JH gene segments with dele-
tion of the intervening sequences during precursor-B cell
differentiation to generate a functional VDJ exon.15 The
VDJ exon is initially spliced to the Cm exons. During an im-
mune response, genomic Ig class switch recombination can
take place to replace theCm exons for one of the otherCH re-
gions. This process is mediated by the Ig switch regions.16
Similar to V(D)J recombination, Ig class switch recombina-
tion involves the genomic deletion of a large intervening
DNA sequence.
Gross deletions involving IGHM can be up to 300 kb and
can include upstreamDH and VH gene segments and down-
stream constant gene regions.11–13 We hypothesized that
the complexity of the IGH locus contributes to the in-
creased incidence of IGHM-disrupting gross deletions. Pos-
sible mediators are the RSS and Ig switch regions, which are
target sequences for B cell-speciﬁc recombination events.
Furthermore, germline duplications and deletions have
been described in either the VH region or involving the
CH regions.17–21 Whereas VH deletions are commonly re-
garded as polymorphisms,22 constant gene deletions can
result in Ig subclass deﬁciencies.23–25 The CH regions con-
tain high degrees of sequence homology, and the altered
haplotypes are thought to be the result of mispairing be-
tween highly homologous regions and subsequent un-
equal crossing-over during meiosis.18–21,26,27
In this study, we aimed to identify mechanisms that un-
derlie the high frequency of gross deletions disrupting
IGHM and Artemis as compared to BTK. Breakpoint analysis
suggested either the involvement of TEs or large homolo-
gous regions rather than recombinationmotifs.We consid-
ered that the colocalization of gross deletion breakpoints
with TEs was not coincidental, and we hypothesized that
the TE content of a gene is related to the gross deletion fre-
quency. This hypothesis was tested on 20 genes disrupted
in human disease.
Material and Methods
Patient DNA Isolation and PCR Ampliﬁcation
Genomic DNA was isolated from post-Ficoll PB granulocytes with
the GenElute Mammalian Genomic DNA Miniprep Kit (Sigma-
Aldrich, St. Louis, MO). The sizes of the gross deletions in IGHM-,
BTK-, andArtemis-deﬁcientpatientsweredeterminedwithscanning
PCRs for gene segments, exons, and subsequently for intronic re-
gions. Sevenunrelated IGHM-deﬁcient patients with a homozygous
gross deletion were studied. Of these patients, three were previously
published as having a gross deletion (F2, F7, and SIOC),11–13 and the
other fourwerenewly identiﬁed (BN, ID392, ID393,and ID394). Fur-
thermore, we studied three unrelated patients with a hemizygous
deletion of BTK (ID113, ID434, ID440) and four unrelated Artemis-
deﬁcient patients, three of which are from consanguineous parents
carrying a homozygous deletion (ID020, ID024, ID389) and one pa-
tient with a compound heterozygousArtemis deletion (ID124). PCR
reactions were essentially performed as described before with
primers that were designed to speciﬁcally amplify 200–600 bp of
DNA (primer sequences available upon request).28The AmLong-Range, Ligation-Mediated PCR and DNA
Sequencing for Analysis of the Breakpoint Junction
Long-range (LR-)PCRwas performed as described before29 with the
appropriate forward and reverse primers that were used to map the
gross deletion boundaries.
Ligation-mediated (LM-)PCR was essentially performed as de-
scribed before30 with newly designed primers. Aliquots of 1 mg
high-molecular-weight DNA were digested with blunt-end restric-
tion enzymes (DraI,HincII, PvuII, and StuI), and50mMof an adap-
tor (Clontech, Palo Alto, CA)was ligated to both ends of the restric-
tion fragments. The ligationproductswere subjected to two rounds
of PCR with nested adaptor-speciﬁc primers AP1 and AP2 (Clon-
tech) and sets of primers designed upstream of the 50 end of the
breakpoint. Atypical bands that appeared from patient’s DNA, but
not from control DNA, were excised from the gel, puriﬁed with
the QIAquick Gel Extraction Kit (QIAGEN, Valencia, CA), and se-
quenced on anABI Prism3100 sequence detection system (Applied
Biosystems, Foster City, CA).
Human Disease-Causing Mutation Data
Mutation data of genes disrupted in human disease were extracted
from the February 2007 release of the human gene mutation data-
base (HGMD).1 To calculate the gross deletion frequency, we in-
cluded the newly described gross deletion alleles from IGHM- and
Artemis-deﬁcient patients from this study and newly identiﬁed
BLNK mutations (unpublished results from M.v.d.B. and from
M.E.C.).
Sequence Analysis of Genes and Breakpoint Regions
Sequences of the IGH locus (NCBI: NG_001019.5) and the BTK,
Artemis (DCLRE1C), BLNK, APC, ATM, BRCA1, BRCA2, CFTR,
DMD, Factor VIII (F8), FANCA, HPRT1, LDLR, MECP2, MLH1,
MSH2, NF1, RB1, and VWF genes including 10 kb upstream and
downstream sequences, extracted from Ensembl v42 (Dec
2006),31 were annotated with TE-derived interspersed repeats by
the CENSOR software tool of the Repbase database.32 To obtain
representative TE content frequencies, only genes spanning
more than 50 kb were included.
The identiﬁed breakpoint regions were aligned with the gene
sequences extracted from public databases. The Genewindow
website was used to identify whether mismatches with standard
sequences were previously described polymorphisms.33 Complex-
ity analysis of 525 bp ﬂanking the breakpoint regions was
performed to examine the potential contribution of local se-
quence structure to the mechanism of gross deletion in the IGH
locus and the BTK and Artemis genes.3,34 In addition, the same re-
gionwas scanned for the presence of 24 sequencemotifs known to
be associated with site-speciﬁc recombination, mutation, cleav-
age, and gene rearrangement.2 The sequences51000 bp ﬂanking
the breakpoint regions were annotated with TEs by the CENSOR
software tool of the Repbase database.32 The nucleic acid dot
plot tool was used to study the homology between the Artemis
gene and the genomic region 82 kb 50 of Artemis. A 19 nucleotide
window size was chosen in which the mismatch limit was set at 0.
Statistical Analysis
Differences in gross deletion frequencies were analyzed with
the nonparametric Mann-Whitney U test (exact test; one-tailed;
p < 0.05) in both the SPSS and the MatLab programs, yielding
exactly similar results.erican Journal of Human Genetics 82, 320–332, February 2008 321
Results
Identiﬁcation of Five Unique Gross Deletion
Breakpoint Junctions in Seven Homozygous
IGHM-Deﬁcient Patients
DNAmaterial was collected from four previously described
and three newly identiﬁed unrelated patients with a full
block in precursor-B cell differentiation in bonemarrow re-
sulting from a homozygous deletion of IGHM. For each of
these seven patients, the extent of the deletions was stud-
ied, which resulted in the characterization of ﬁve unique
breakpoint junctions within the IGH loci of the seven
IGHM-deﬁcient patients (Figure 1A).
Patient BN was found to carry a homozygous IGHM
deletion of 732 kb starting 50 of VH3-37 and ending 30 of
IGHGP (Figure 1A). The junction contained 9 bp of unique
sequence that could not be assigned to the 50 or 30 break-
point region sequences (Figure 1B). The two mismatches
with the 50 breakpoint region corresponded to previously
described single nucleotide polymorphisms (SNP).
In addition to the IGHM deletion, the homozygous IGH
locus of patient BN had a 33 kb deletion involving
the VH3-39, VH7-40, and VH3-41 gene segments. About
1.3 kb sequence between the two gross deletions, includ-
ing the VH3-38 gene segment, was maintained at the locus.
The junction of the 33 kb deletion contains 2 bp microho-
mology and shows high degrees of sequence homology
between the regions downstream of the breakpoints (Fig-
ure 1B). This deletion appeared similar to a deletion (Del III)
that was mapped before but not cloned.22 None of the
other six IGHM patients carried this deletion, and it was
found in 15 of 66 controls, who did not have the 732 kb
IGHM deletion; 7 were heterozygous and 8 homozygous
(23 alleles). Consequently, the 33 kb deletion of VH3-39,
VH7-40, and VH3-41 is a common polymorphism present
in 17% of the IGH alleles in controls.
Identical breakpoint junctions were found in two unre-
lated Caucasian patients: ID393 and ID394. Both patients
lack 578 kb of genomic DNA starting 50 of the VH3-19
gene segment and ending 30 of the IGHG4 constant region.
The two breakpoints were fused with a three-nucleotide
microhomology region (Figure 1B). Analysis of 21 SNPs in
VH3-20, IGHE, and IGHA2 revealed no differences between
the patients, indicating that they carry the same allele.
The twounrelated Turkishpatients ID392 and F7 also car-
ried deleted alleles with identical breakpoint junctions. The
deletions span 126 kb of genomic DNA starting 50 of the
KIAA0125 element between the VH6-1 and DH1-1 gene
segments and ending 30 of IGHD (Figure 1B). One nucleo-
tide microhomology was found at the breakpoint fusion
(Figure 1B). Interestingly, 50 of the breakpoint junction of
both patients, a small deletion of 19 bp with 6 bpmicroho-
mology in the fusionwas found. This small deletionwasnot
seen in 82 controls. We suggest that both the small and the
gross deletion occurred in the same event. SNP analysis
of the breakpoint fusion region, VH3-20, VHIV-20.1, and322 The American Journal of Human Genetics 82, 320–332, FebruaryIGHE PCR amplicons showed no polymorphic differences
between the alleles of patients ID392 and F7, indicating
that both patients inherited the allele from a common an-
cestor.
The gross deletion in patient F2 spanned 71 kb from
DH1-1 to IGHM. Interestingly, the junction contained
a 51 nt insertion, which aligned almost perfectly with the
intronic region between DH4-23 and DH5-24, 37 kb down-
stream of the 50 breakpoint (Figure 1A). Consequently,
two deletions were found; the two junctions contained 1
and 3 nucleotides of microhomology, respectively (Fig-
ure 1B). The 50 deletion that does not involve IGHM was
not found in 66 controls. Therefore, it does not appear to
be a common polymorphism.
Patient SIOC had a gross deletion of 146 kb extending
from DH6-13 to IGHG3 (Figure 1A). The junction contains
four nucleotides of microhomology (Figure 1B).
We identiﬁed ﬁve unique breakpoint junctions in seven
unrelated homozygous IGHM-deﬁcient patients. Two pre-
viously identiﬁed IGHM-deﬁcient patients, who were het-
erozygous for a gross deletion,13 did not carry one of the
identiﬁed breakpoint junctions and each is likely to carry
a unique deletion.
IGH Breakpoints Are Associated with TEs
The ﬁve identiﬁed IGH breakpoints were located in in-
tronic sequences without any apparent homology between
the 50 and 30 breakpoint ﬂanking regions. In order to study
the involvement of TEs, 2 kb DNA sequences ﬂanking the
breakpoint regions were screened against a reference col-
lection of repeats. As shown in Figure 2, we found that 2
of the 10 IGHM-deleting breakpoints were located in or
near a type 1 LINE and 6 were located in or near endoge-
nous retroviral (ERV) sequences, which belong to the class
of LTR retrotransposons. The remaining two breakpoints
were located in unique sequences. Consequently, in al-
most all gross deletions involving IGHM, the breakpoints
of fusion partners are located in or near TEs of the same
class. TEs are present throughout the genome and they
have been implicated in genomic rearrangements,5,6 so
the localization of gross deletions in or near TEs could be
a general phenomenon.
Similar to IGHM, Gross Deletion Breakpoints in BTK
and Artemis Frequently Occur in TEs
In addition to IGH, gross deletions disrupting BTK or Arte-
mis have been found in primary immunodeﬁciencies
(PID). Although only 5 of 37 identiﬁed breakpoints have
been analyzed at sequence level, similar to IGHM gross de-
letions, most of the BTK breakpoints were located in
TEs.35,36
In addition to the published sequences, we identiﬁed
three additional gross deletions in BTK-deﬁcient patients.
The eight deletions are spread throughout the gene and
range in size from 2.6 to 38.2 kb deleting one or more
exons (Figure 3A). The results of the breakpoint sequence
analyses of our three patients were in line with previous2008
Figure 1. Gross Deletion Breakpoints of Seven Unrelated Homozygous IGHM-Deficient Patients
(A) IGHM gross deletions ranging in size from 71 to 732 kb were identified with a PCR approach. An additional 33 kb deletion 1.6 kb
upstream of the IGHM deletion disrupts three VH gene segments in patient BN.
(B) Sequences of the five unique IGHM-deleting breakpoint junctions and one novel VH deletion polymorphism. The IGHM-deletion break-
point junction of patient BN shows a 9-nucleotide insertion (caps). The two mismatches with the 50 breakpoint region are previously
described SNPs. The 33 kb VH-deletion polymorphism in patient BN shows a dinucleotide microhomology (boxed). The IGHM deletion
in patients ID393 and ID394 shows a trinucleotide microhomology. The IGHM deletion in patients ID392 and F7 shows one nucleotide
microhomology. The small deletion and the mismatch with the 50 breakpoint region are not previously described polymorphisms. The
IGHM deletion in patient F2 shows a 51 nucleotide insertion that corresponds to the intronic region between DH4-23 and DH5-24. The
50 junctions showed one nucleotide microhomology, whereas the 30 junction showed three nucleotides of microhomology. The mismatch
within the 51 nt insertion is not a previously described SNP. Complexity analysis of 525 bp flanking the breakpoints showed that the
deletions in patients ID393, ID394, and SIOC are potentially mediated by a hairpin loop (inverted repeats). The deletion in patients ID392
and F7 could have been mediated by a knot structure. Furthermore, the deletion in patient F2 is potentially mediated by combination of
a knot structure for the 50 joint and a Mo¨bius loop for the 30 joint.observations (Figures 3B and 3C). In six of the eight pa-
tients, both the 50 and 30 breakpoints were located in Alu
elements (SINE) and showed high degrees of sequence ho-
mology (Figure 3B).35,36 Interestingly, two Alumotifs were
each involved in two independent recombination events;
the 30 breakpoints of patients ID434 and P4 and the 30
breakpoint of patient 0850 and the 50 breakpoint of patientThe AmP4 were located in the same Alu element. In both cases, the
breaks occurred at distinct sites within the Alu motifs, al-
though the 30 breakpoint of patient P4 is located closely
to the 30 breakpoint of patient ID434 (Figure 3B).
The gross deletion breakpoints in patients ID440 and
0703 were not located in Alu elements and showed no
sequence homology within 50 bp. Two nucleotides wereerican Journal of Human Genetics 82, 320–332, February 2008 323
inserted in the junction of patient ID440, whereas patient
0703 had one nucleotide of microhomology at the junc-
tion.35 In patient ID440, the breakpoints were located
closely to SINE elements: the 50 breakpoint downstream of
a MIRb and the 30 breakpoint downstream of an Alumotif.
The 50 breakpoint of patient 0703 was located near a MIRb
(SINE2) sequence, whereas the 30 breakpoint was located
in a LINE1 element and near an Alumotif (Figure 3C).
In general, the gross deletions in BTKwere much smaller
than those characterized in the IGH locus. This was espe-
cially noted for the Alu-Alu recombination events. Detailed
TE annotation of breakpoint ﬂanking regions (Figure 3C)
showed that all eight gross deletion breakpoints in BTK
were located in or near TEs.
In contrast to BTK, Artemis gross deletion breakpoints
have not been sequenced to date.We identiﬁed two unique
breakpoint regions in four Artemis-deﬁcient patients (Fig-
ure 4A). Although the breakpoint regions appeared similar,
four unique breakpoint junctions were identiﬁed in pa-
tients ID020, ID024, and ID124, all resulting in the loss of
82 kb including exons 1–3 (Figure 4B). All eight 50 and 30
breakpoint regions contained a high density of TEs (Fig-
ure 4C), and the breakpoints were located either in (ID020
and ID024) or near (ID124, both alleles) a TE. Strikingly,
the regions that contained the 50 breakpoints were highly
homologous to the regions that contained the 30 break-
points. Sequence alignment between the Artemis gene and
80 to 55 kb upstream region revealed a highly homolo-
Figure 2. IGHM Deletion Breakpoints Are Located in or near
Transposable Elements
51000 bp flanking the 10 unique breakpoints involved in IGHM
deletions were analyzed for the presence of transposon-derived re-
petitive elements. No VH, DH, JH gene segments or constant gene
exons were present in these regions.324 The American Journal of Human Genetics 82, 320–332, Februargous region of ~12 kb (Figure 4D). Thus on top of TE
involvement, these breakpoints show high degrees of
sequence homology.
Patient ID389 had an 11.1 kb genomic deletion includ-
ing Artemis exons 10, 11, and 12. The 50 and 30 breakpoints
were located in Alu sequences and the joint showed high
degrees of sequence homology (Figures 4B and 4D).
High Total TE Content Associated with Increased
Incidence of Gene-Disrupting Gross Deletions
Although the incidence of gross deletions in IGHM, BTK,
and Artemis differs greatly (58%, 6%, and 56% of disease-
causing mutations, respectively), the majority of gross de-
letions in all three genes show involvement of TEs. To ad-
dress this difference, we determined the total TE content
in these genes and compared this TE content to that of
the total human genome (Figure 5A). We found that the
TE content of IGH (41%) and Artemis (45%) was higher
than the average of the human genome (37%). In contrast,
only 29% of the BTK gene consists of TE-derived repeats.
Similar analysis was performed for BLNK (MIM 604515),
which is also a PID gene of >50 kb in size. Only four dis-
ease-causing mutations in BLNK have been identiﬁed,
which were all microlesions (unpublished observations
fromM.v.d.B. andM.E.C.).37 Similar to BTK, a reduced frac-
tion of the BLNK gene consisted of TEs (30%; Figure 5A).
These observations suggest that a high total TE content
of a gene is associated with an increased gross deletion
frequency found in gene disruptions underlying human
disease.
Of the four types of TEs that are most frequently found
in the human genome (LINE1, ERV, Alu, MIR), the ERV
and LINE1 content is over-represented in IGH compared
to the average in the human genome (Figure 5B). In con-
trast, BTK and Artemis have very few of these TE elements,
whereas twice as much of their genomic sequence is de-
rived from Alumotifs as compared to the average in the hu-
man genome. None of the four dominant types of TEs was
overrepresented in BLNK. Whereas the total TE content
seemed to correlate to the gross deletion frequency, gross
deletions involved mainly TEs belonging to a class that is
overrepresented in a gene, irrespective of the total TE con-
tent. The involvement of ERV elements in 4 out of 10 IGH
gross deletion breakpoints and the involvement of Alu ele-
ments in 12 out of 16 BTK breakpoints is relatively high
when considering that they constitute only 16% and
18% of the IGH and BTK gene sequences, respectively.
However, ERV elements constitute 39% of TEs in IGH
and Alu elements constitute 62% of TEs in BTK. Therefore,
if one assumes that gross deletionsmainly occur in TEs, the
involvement of relatively overrepresented TE subclasses
appears to be as expected by chance.
TEs and Gross Deletions in Human Disease Genes
We identiﬁed a trend between the TE content and the gross
deletion frequency of four genes implicated in primary im-
munodeﬁciencies. This is a small set of genes and with they 2008
Figure 3. Gross Deletions in BTK Are Mainly Associated with Alu-Alu Mispairing and Crossing Over
(A) Mapping of the BTK gross deletions in three unrelated patients by a PCR approach. The gross deletions in patients 0703, 0850, 2430,
2433,35 and P436 have been described before.
(B) Sequences of the three newly identified breakpoint junctions compared to control sequences. The breakpoint junction of patient
ID440 shows a TT insertion, which could be palindromic nucleotides. Microhomology regions at the junctions of patients ID113 and
ID434 are boxed. Complexity analysis of525 bp flanking the breakpoints did not result in a likely mediator for patient ID440, whereas
the breakpoint in patients ID113, 0850, ID434, P4, 2430, and 2433 appear to be mediated by homologous recombination and in patient
0703 by a knot structure (inversion of inverted repeats). The 30 breakpoint of patient P4 was located close to the 30 breakpoint of patient
ID434, and the six nucleotides of microhomology are indicated by bold font in the 30 breakpoint region of ID434.
(C)51000 bp flanking the 16 unique BTK gross deletion breakpoints were analyzed for transposon-derived repetitive elements. In ad-
dition, BTK exons are indicated. The 30 breakpoints of patients ID434 and P4 were located in the same Alu element, and the 30 breakpoint
of patient 0850 and the 50 breakpoint of patient P4 were located in the same Alu element.exception of BTK, only a limited number of disease-causing
mutations have been identiﬁed in these genes: 12 IGHM
mutations, 13 Artemis mutations, and 4 BLNK mutations
(Table 1). Therefore, we decided to test ourmodel in a larger
set of more extensively studied human disease genes. A lit-
erature search yielded a set of 16 additional genes for which
>200 unique mutations were recorded in the HGMD and
that spanned >50 kb of genomic DNA. The gross deletion
frequency of these genes in human disease was extracted
from the HGMD,1 and the TE content was determined
withCENSOR.32 Similar towhatwas observed for the initial
four genes, the genes with a higher TE content tended to
show an increased frequency of gross deletions (Table 1).The AmA strong increase in the gross deletion frequency was noted
in genes that showed >40% TE content (Table 1). The me-
dian gross deletion frequency was 6% for genes with
%40% repetitive elements, compared with 14% for genes
with >40% repetitive elements (Figure 6A). This difference
was found to be highly signiﬁcant between both groups of
genes (p ¼ 0.01).
Gross deletions are currently deﬁned as>20 bp, which is
a crude cut-off value. TEs in the human genome range in
size from about 300 bp to several kb. This would imply
that only gross deletions spanning more than a few hun-
dred bp can show involvement of two independent TEs
in a gross deletion. To test whether this holds true,erican Journal of Human Genetics 82, 320–332, February 2008 325
Figure 4. Gross Deletions in the Artemis Gene Suggest Alu-Alu Mispairing and Crossing Over
(A) Mapping of the homozygous Artemis gross deletions in four unrelated patients with a PCR approach.
(B) The 50 and 30 unique breakpoint regions in patients ID020, ID024, and ID124 are located within 1 kb in two highly homologous 12 kb
regions. The mismatch in the breakpoint region of patient ID024 with both the 50 and 30 control sequences is not a previously identified
SNP. Complexity analysis of local sequences indicates that the deletions in these patients and in patient ID389 are potentially mediated
by homologous recombination.
(C) The breakpoint regions identified in patients ID020, ID024, and ID124 show a high density of TEs. The deletion breakpoints of pa-
tients ID024 and ID389 are located in Alu elements, and of patient ID020 in an LTR retrotransposon.
(D) A DNA dot plot generated from the alignment between exon 1 to intron 9 of the Artemis gene with a region 82 kb 50 of Artemis shows
a highly homologous region of ~12 kb. The 50 and 30 breakpoints of patients ID020, ID024, and ID124 are located in the homologous regions.additional analyses were performed with cut-off values for
gross deletions of 200 and 400 bp. These analyses mainly
showed a remarkable reduction in gross deletion frequency
of MECP2 (300005) from 34% to 13% with a cut-off of
400 bp. No difference was found for the median values
and the signiﬁcance for the 200 bp cut-off, whereas the
medians were 5% and 13% for genes with %40% and
>40% sequence derived from TEs, respectively, with p ¼
0.007 (Figure 6B). In conclusion, genes with a TE content
of >40% have a signiﬁcantly increased gross deletion fre-
quency in mutations underlying human disease. The sig-
niﬁcance increased slightly when the cut-off for gross dele-
tions is increased to 400 bp.
In addition to the total TE content, the content of the
four most abundant TE subclasses (ERV, LINE1, Alu, and326 The American Journal of Human Genetics 82, 320–332, FebruarMIR) was determined for the 20 genes to study whether
the overrepresented elements were speciﬁcally involved
in gross deletions (Table 1). Although the breakpoint fu-
sion sequence of only a small fraction of the reported gross
deletions has been determined, mainly the overrepre-
sented TE subclasses appeared to be involved in gross dele-
tion breakpoints (Table 1).
Discussion
We characterized the gross deletion breakpoints in IGHM-,
BTK-, and Artemis-deﬁcient patients to explain the high
frequency of gross deletions in IGHM and Artemis com-
pared to BTK. IGHM gross deletion breakpoints were noty 2008
located in or near RSS or Ig switch regions, but similar to
most gross deletions involving BTK or Artemis, they were
associated with TE-derived repeats. We analyzed potential
TE involvement in gross deletion frequencies on a total
set of 20 genes disrupted in human disease. We found
that genes with a high TE content (>40%) showed an in-
creased frequency of gross deletions when disrupted in
human disease. We conclude that, similar to suggestions
based on limited sequence data from other genes disrupted
in human disease, TEs are likely mediators of gross dele-
tions in IGHM, BTK, and Artemis. Consequently, we pro-
pose a role for TEs in the high frequency of gross deletions
involving IGHM, whereas the high gross deletion fre-
quency of Artemis gene disruptions is potentially mediated
by the high TE content and facilitated by mispairing of the
~12 kb region that encompasses exons 3–9 with a region
>60 kb upstream of the Artemis gene.
In this study, ﬁve unique breakpoint regions were char-
acterized in seven unrelated IGHM-deﬁcient patients. The
breakpoints were scattered throughout the locus in introns
within the VH, DH, and constant regions, thereby indicat-
ing that there was no preferential targeting of a speciﬁc re-
gion. Interestingly, no colocalization with RSS or Ig switch
regions was found. Whereas such sequences are the potent
recombination sequences in speciﬁc stages during B cell
development, they do not appear to be prone to recombi-
Figure 5. Highly Variable TE Content in Four Genes
(A) The IGH and Artemis loci contain a high TE content compared to
the average of the human genome, whereas the BTK and BLNK
genes have decreased TE content.
(B) The LINE, ERV, Alu, and MIR elements are the most common TEs
found in the human genome. IGH consists of increased ERV and
LINE repeats, whereas BTK and Artemis mainly contain Alu ele-
ments. BLNK does not display increased presence of any of the
four types of elements as compared to the average of the human
genome.The Amnation in germline cells. It is therefore highly unlikely that
the B cell-speciﬁc recombination characteristics of the
IGH locus underlie the high frequency of gross deletions
involving IGHM.
The ﬁve IGHM deletions did not show high sequence
homology between the 50 and the 30 breakpoint regions.
Therefore, it is unlikely that the gross deletions were the re-
sult of mispairing of homologous sequences and unequal
crossing-over as has been observed in recurrent Ig subclass
deletions.27 The ﬁve breakpoint junctions did show the
characteristics of NHEJ, withmicrohomology in four joints
and an insertion of six nucleotides in the ﬁfth. No com-
mon sequence motifs were found in the breakpoint re-
gions, whereas complexity analysis revealed that short
repetitive sequences are likely mediators of the unequal
repair.
The majority of IGHM-deleting gross deletion break-
points were located in or near TE-derived repeats. Interest-
ingly, the involved elements (LINEs and LTR retrotranspo-
sons) were overrepresented in the IGH locus as compared
to the average in the human genome. On the other hand,
the gross deletions identiﬁed in BTK- and Artemis-deﬁcient
patients mainly involved SINEs. In contrast to IGH, these
SINEs are speciﬁcally overrepresented in BTK and Artemis.
Furthermore, the high frequency of gross deletions in IGH
and Artemis as compared to BTK and BLNK was associated
with a high total TE content. These observations suggest
a role for TEs in mediating gross deletions. Involvement of
TEs has been shown before.5,6 However, by analysis of 20
genes disrupted in human disease, we are the ﬁrst (to our
knowledge) to show that the total TE content is associated
with a signiﬁcantly increased frequency of gross deletions
as cause of gene disruption.
The gene disruptions included in this study were origi-
nally identiﬁed because they resulted in a genetic disorder.
We used the relative number of disruptions caused by gross
deletions, thereby assuming that the chance that a muta-
tion or a deletion results in disease is similar for every
gene. Furthermore, the detection of gross lesions is more
difﬁcult than microlesions. Because in our study we in-
cludedmultiple relatively large genes that have been exten-
sively studied with respect a genetic disorder, we assumed
that this evened out in the statistical analysis.
The role of TEs in mediating gross deletions is difﬁcult to
examine. In general, the breakpoints analyzed in this study
involved at least two double-stranded DNA breaks in dis-
tant genomic locations (2.6–732 kb) that were placed in
physical proximity and incorrectly repaired. Complexity
analysis showed that small repeat fragments are likely me-
diators of the incorrect repair. This mechanism is quite
similar to what is seen in microlesions, which are thought
to result from slipped mispairing of single-stranded DNA
in the replication fork. Because the stretches of single-
stranded DNA in the replication fork do not extend be-
yond 1000–2000 bp, additional factors are required to me-
diate colocalization of two distant genomic regions and
double-stranded DNA break induction.erican Journal of Human Genetics 82, 320–332, February 2008 327
Table 1. Correlation of Gross Deletions Incidence and TE Content
Gene
Gene Size (kb)
Incl.510 kb
Sequence
Gross Deletion
Frequencya
(# Gross Deletions/#
Total Mutations)
Motif Fractionb
(% Total
Sequence)
ERVc
(% Total
Sequence)
LINE1c
(% Total
Sequence)
Aluc
(% Total
Sequence)
MIRc
(% Total
Sequence)
Breakpoint
Mediators References
IGHMd (MIM 147020) 1280 58% (7/12) 41% 16.1 19.1 2.8 0.2 ERV, LINE1
BTK (MIM 300300) 57 7% (37/523) 29% 0.1 4.6 18.0 2.9 Alu, MIR 35,36
BLNKe (MIM 604515) 100 0% (0/4) 30% 3.8 10.9 7.9 4.2 –
Artemisd (MIM 605988) 66 56% (9/16) 45% 3.1 11.3 23.3 4.0 Alu
CFTR (MIM 602421) 209 3% (35/1208) 27% 5.2 9.8 4.1 3.0 ?
DMD (MIM 300377) 2112 35% (255/735) 29% 5.3 11.8 5.3 1.9 Alu, LINE1 5
MECP2 (MIM 300005) 96 34% (108/319) 31% 1.7 8.8 19.4 1.0 Alu 43,44
APC (MIM 175100) 128 5% (34/696) 32% 3.5 7.9 13.3 2.2 Alu 45,46
VWF (MIM 193400) 196 6% (12/206) 33% 3.3 12.1 10.9 2.7 Alu 47
MLH1 (MIM 120436) 77 11% (46/415) 36% 2.4 8.2 16.5 2.3 Alu, LINE1 48
NF1 (MIM 162200) 299 6% (45/718) 37% 4.6 13.3 13.8 1.5 Alu 49
BRCA2 (MIM 600185) 104 1% (7/504) 39% 4.2 8.3 13.8 2.0 Alu 50
BRCA1 (MIM 113705) 101 6% (45/750) 40% 2.1 1.7 31.5 2.9 Alu 51
ATM (MIM 607585) 166 8% (35/421) 40% 1.3 20.3 11.7 1.3 Alu, LINE1 52
FANCA (MIM 607139) 99 28% (66/234) 42% 4.3 3.7 30.4 2.6 Alu 53,54
HPRT1 (MIM 308000) 60 12% (28/232) 43% 3.8 6.4 21.9 4.2 Alu, LINE1 55
MSH2 (MIM 609309) 100 16% (56/346) 45% 4.1 5.9 26.2 5.7 Alu 48,56
RB1 (MIM 180200) 198 8% (35/418) 47% 4.1 26.4 6.9 1.7 ?
LDLR (MIM 606945) 64 11% (94/866) 51% 2.0 1.9 41.0 4.5 Alu 57–61
F8 (MIM 306700) 207 11% (95/885) 58% 10.7 32.3 7.0 1.0 Alu, LINE1 62–66
Total 3.2 3 106f 6% (2962/53200) 37%f 6.8f 14.6f 9.3f 1.8f –
Bold text indicates values clearly higher than the total values in the bottom row.
a HGMD February 2007.
b TE content was determined with CENSOR.
c The four most abundant TE subclasses; ERVs are LTR retrotransposons, LINE1s are the most common LINEs, and Alu and MIR are the most common SINEs.
d Statistics include alleles from patients that are described here.
e Statistics include alleles from unpublished patients (M.v.d.B., M.E.C.).
f Data obtained on the total human genome sequence.As recently discussed by Hedges and Deininger, the dis-
ruptive potential of TEs might result from two mecha-
nisms.6 First, the sequencehomologybetween the involved
elements facilitates incorrect homologous repair. Second,328 The American Journal of Human Genetics 82, 320–332, Februarbecause the endonuclease products of TEs are designed to
preferentially target TEs, theymight contribute to genomic
instability at these sites. The ﬁrst mechanism potentially
contributes to the gross deletions in BTK and Artemis thatFigure 6. Genes Disrupted in Human Inherited Diseases with a Transposon-Derived Repetitive Element Content of >40% Are
Significantly More Frequently Disrupted by Gross Deletions than Genes with %40% TE Content
The frequency of gross deletions was determined from 20 genes disrupted in human inherited disease. A surprising increase in gross de-
letion frequency was found in genes with >40% TE content.
(A) The gross deletion frequency of 20 genes is shown for genes with%40% and >40% TE content. Every dot represents an individual
gene. The gross deletion frequency was significantly increased in genes with >40% TE content as determined with a nonparametric test.
(B) The significance increases slightly when the cut-off set for gross deletions is increased from >20 bp to >400 bp.y 2008
showed high levels of homology between the 50 and 30
breakpoint regions. The endonuclease product of LINE1,
on the other hand, might contribute to gross deletions in
IGHM.
The accumulation of transposon-derived repetitive ele-
ments in heterochromatin might be a third mechanism
that contributes to gross deletion formation (reviewed by
Dimitri et al.38). This localization of TEs could result from
preferential insertion of these elements in DNA that is
packed in heterochromatin.39 However, it is well possible
that it is a defense mechanism of the host cell to repress ex-
pression of TE products by actively packing these elements
in heterochromatin.40,41 Irrespective of this, heterochro-
matic regions are compact clusters of genomic DNA. It
seems therefore likely that genomic regions with high TE
content are tightly packed in heterochromatin, and this
is a mechanism by which TEs mediate colocalization of
distant genomic regions.
Microinsertions andmicrodeletions are assumed to result
from slippedmispairing, but thismechanism has been pro-
posed to underlie some of the identiﬁed deletions that were
>20 bp.42 This is not remarkable because it is suggested to
result from mispairing of ssDNA in the replication fork
and the length of ssDNA is 1000–2000 bp. However, the
size of TEs ranges from few hundred to a few thousand bp.
Therefore, the involvement of TEs in the generation of
deletions smaller than a fewhundred bp is unlikely.We sug-
gest deﬁning gross deletions to be larger than 400 or even
1000bpbecause this better reﬂects themechanismunderly-
ing these lesions. Ultimately, additional sequence data and
analysis of deletion breakpoints should allow for a more
accurate discrimination ofmicro- and gross deletions based
on the underlying mechanism.
Not all deletions in Artemis were solely associated with
TEs. A recurrent deletion of exons 1–3 was associated
with ~12 kb homology between the 50 and 30 breakpoint
regions. Thus, similar to the VH deletion polymorphism
in patient BN and previously reported CH deletions,27 the
recurrent Artemis exon 1–3 deletion likely results frommis-
pairing between highly homologous sequences.
In this study, we identiﬁed and characterized IGHM,
BTK, and Artemis deletions in patients with primary immu-
nodeﬁciency.Whereas the human IGH locus containsmul-
tiple functionally proven recombination sequences, these
were not observed near IGHM gross deletion breakpoints.
Consequently, we conclude that RSS and Ig switch regions
are unlikely to bemediators of germline deletions. Analysis
of the IGHM, BTK, and Artemis deletion junctions did show
involvement of TEs and formed the basis of our hypothesis
that a high total TE content is correlated to an increased
frequency of gene disruption by gross deletions, which
was conﬁrmed by analysis of 20 genes disrupted in human
disease. Although more sequence data are needed to draw
ﬁrm conclusions on the underlying mechanisms, this
study shows a novel statistical correlation between TE den-
sity and the frequency of gene disruption by gross dele-
tions in human disease.The AmAcknowledgments
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Ensembl, http://www.ensembl.org/Homo_sapiens/index.html
Genewindow, http://genewindow.nci.nih.gov:8080/home.jsp
Human Gene Mutation Database (HGMD), http://www.hgmd.cf.
ac.uk/ac/index.php
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